[1] 李媛秋, 刘剑君, 么鸿雁. 肺癌发病和死亡流行情况与人类发展指数的关系分析[J]. 中国肿瘤, 2019, 28(9):646-650. [2] 张化芝, 郭晓烨, 李晓双,等. 肺癌术后并发肺部感染的病原学分析及影响因素分析[J]. 中华医院感染学杂志, 2018, 28(1):77-80. [3] De Ruysscher D, Faivre-Finn C, Nackaerts K, et al. Recommendation for supportive care in patients receiving concurrent chemotherapy and radiotherapy for lung cancer[J]. Ann Oncol, 2020, 31(1): 41-49. [4] 李乔, 范习刚. 影响肺癌化疗患者发生肺部感染的危险因素分析[J]. 实用癌症杂志, 2020, 35(1):85-87. [5] 姚艳红, 路明, 刘燕娥, 等. 病毒性肺炎的流行对肺癌患者的影响和思考[J]. 中国肺癌杂志, 2020, 23(4):255-260. [6] Schabath MB, Cote ML.Cancer progress and priorities: Lung Cancer[J]. Cancer Epidemiol Biomarkers Prev, 2019, 28(10):1563-1579. [7] Baden LR, Swaminathan S, Angarone M, et al.Prevention and treatment of cancer-related infections, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology[J]. J Natl Compr Canc Netw, 2016,14(7):882-913. [8] Zhang M, Zhang Y, Han Y, et al.Characteristics of pathogenic microbes in lung microenvironment of lung cancer patients without respiratory infection[J]. J BUON, 2021, 26: 1862-1870. [9] 中国抗癌协会肺癌专业委员会. 2007中国肺癌临床指南[M]. 北京: 人民卫生出版社, 2007:20. [10] 李清杰, 刘运喜. 医院感染防控指南[M]. 北京: 人民军医出版社, 2010:47. [11] 尚红, 王毓三, 申子瑜. 全国临床检验操作规程[M]. 北京:人民卫生出版社, 2015:1-8. [12] Belluomini L, Caldart A, Avancini A, et al.Infections and immunotherapy in lung cancer: A bad relationship?[J]. Int J Mol Sci, 2020, 22(1):42. [13] Ardura MI, Bibart MJ, Mayer LC, et al.Impact of a best practice prevention bundle on Central Line-associated Bloodstream Infection (CLABSI) rates and outcomes in pediatric hematology, oncology, and hematopoietic cell transplantation patients in inpatient and ambulatory settings[J]. J Pediatr Hematol Oncol, 2021, 43(1):e64-e72. [14] Parodi R L, Lagrutta M, Tortolo M, et al.A multicenter prospective study of 515 febrile neutropenia episodes in Argentina during a 5-year period[J]. PLoS One, 2019, 14(10): e0224299. [15] 孔羽, 崔嬿嬿, 韩月玲, 等. 老年肺癌根治术后患者院内感染的相关因素分析[J]. 癌症进展, 2019, 17(21):2589-2592. [16] 蒋爱民, 马宇彦, 刘娜, 等. 肺癌患者院内感染微生物学特点及预后因素分析[J]. 现代肿瘤医学, 2022, 30(9):1598-1602. [17] 刘宇, 王垚. 老年肺癌患者化疗后肺部感染的病原菌分布及其对免疫功能的影响[J]. 现代肿瘤医学, 2019, 27(2):233-236. [18] 程玲, 张利, 马艳艳, 等. 危重症管理小组对肺癌并发重症肺部感染患者临床疗效及预后的影响[J]. 癌症进展, 2018, 16(14):1811-1814. [19] 彭丽清, 朱梦莉, 范学朋, 等. PiCCO联合快速反应体系对感染性休克液体复苏的监控效果分析[J]. 中华医院感染学杂志, 2019, 29(18):2763-2766. [20] 张力苹, 谢维宁, 林卉, 等. 恶性肿瘤合并血流感染患者的短期预后的影响因素[J]. 分子影像学杂志, 2021, 44(2):370-377. [21] Hamaker ME, Oosterlaan F, van Huis LH, et al. Nutritional status and interventions for patients with cancer - A systematic review[J]. J Geriatr Oncol, 2021;12(1):6-21. [22] Kim YJ, Jung SM, Kang J, et al.Risk factors for extended-spectrum beta-lactamase-producing Enterobacteriaceae infection causing septic shock in cancer patients with chemotherapy-induced febrile neutropenia[J]. Intern Emerg Med, 2019, 14: 433-440. [23] 陈红利, 孔旭东,徐升, 等. 长,短效重组人粒细胞刺激因子治疗乳腺癌化疗后白细胞减少症的效果[J]. 河南医学研究, 2021, 30(36):6757-6760. |